Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2020

01-12-2020 | Antiepileptic Drugs | Research article

Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs

Authors: Laura J. Bonnett, Jane L. Hutton, Anthony G. Marson

Published in: BMC Medical Research Methodology | Issue 1/2020

Login to get access

Abstract

Background

Predictive models within epilepsy are frequently developed via Cox’s proportional hazards models. These models estimate risk of a specified event such as 12-month remission. They are relatively simple to produce, have familiar output, and are useful to answer questions about short-term prognosis. However, the Cox model only considers time to first event rather than all seizures after starting treatment for example. This makes assessing change in seizure rates over time difficult. Variants to the Cox model exist enabling recurrent events to be modelled. One such variant is the Prentice, Williams and Peterson – Total Time (PWP-TT) model. An alternative is the negative binomial model for event counts. This study aims to demonstrate the differences between the three approaches, and to consider the benefits of the PWP-TT approach for assessing change in seizure rates over time.

Methods

Time to 12-month remission and time to first seizure after randomisation were modelled using the Cox model. Risk of seizure recurrence was modelled using the PWP-TT model, including all seizures across the whole follow-up period. Seizure counts were modelled using negative binomial regression. Differences between the approaches were demonstrated using participants recruited to the UK-based multi-centre Standard versus New Antiepileptic Drug (SANAD) study.

Results

Results from the PWP-TT model were similar to those from the conventional Cox and negative binomial models. In general, the direction of effect was consistent although the variables included in the models and the significance of the predictors varied. The confidence intervals obtained via the PWP-TT model tended to be narrower due to the increase in statistical power of the model.

Conclusions

The Cox model is useful for determining the initial response to treatment and potentially informing when the next intervention may be required. The negative binomial model is useful for modelling event counts. The PWP-TT model extends the Cox model to all included events. This is useful in determining the longer-term effects of treatment policy. Such a model should be considered when designing future clinical trials in medical conditions typified by recurrent events to improve efficiency and statistical power as well as providing evidence regarding changes in event rates over time.
Literature
1.
go back to reference Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010;51(5):883–90.CrossRef Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010;51(5):883–90.CrossRef
2.
go back to reference Anon. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia. 1998;39(7):799–803.CrossRef Anon. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia. 1998;39(7):799–803.CrossRef
3.
go back to reference Cockerell OC, Johnson AL, Sander JWAS, Hart YM, Shorvon SD. Remission of epilepsy - results from the National General-Practice Study of epilepsy. Lancet. 1995;346(8968):140–4.CrossRef Cockerell OC, Johnson AL, Sander JWAS, Hart YM, Shorvon SD. Remission of epilepsy - results from the National General-Practice Study of epilepsy. Lancet. 1995;346(8968):140–4.CrossRef
4.
go back to reference Pellock JM, Dodson WE, Bourgeois BF. Pediatric epilepsy: diagnosis and therapy :third edition: springer publishing company; 2008. Pellock JM, Dodson WE, Bourgeois BF. Pediatric epilepsy: diagnosis and therapy :third edition: springer publishing company; 2008.
5.
go back to reference Therneau TM, Hamilton SA. rhDNase as an example of recurrent event analysis. Stat Med. 1997;16(18):2029–47.CrossRef Therneau TM, Hamilton SA. rhDNase as an example of recurrent event analysis. Stat Med. 1997;16(18):2029–47.CrossRef
6.
go back to reference Kelly PJ, Lim LLY. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med. 2000;19(1):13–33.CrossRef Kelly PJ, Lim LLY. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med. 2000;19(1):13–33.CrossRef
7.
go back to reference Berg AT, Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. J Clin Neurophysiol. 1997;14(2):102–10.CrossRef Berg AT, Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. J Clin Neurophysiol. 1997;14(2):102–10.CrossRef
8.
go back to reference Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika. 1981;68(2):373–9.CrossRef Prentice RL, Williams BJ, Peterson AV. On the regression analysis of multivariate failure time data. Biometrika. 1981;68(2):373–9.CrossRef
9.
go back to reference Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1016–26.CrossRef Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1016–26.CrossRef
10.
go back to reference Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1000–15.CrossRef Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. 2007;369(9566):1000–15.CrossRef
11.
go back to reference Bonnett LJ, Tudur Smith C, Smith D, Williamson PR, Chadwick D, Marson AG. Time to 12-month remission and treatment failure for generalised and unclassified epilepsy. J Neurol Neurosurg Psychiatry. 2013;85(6):603–10.CrossRef Bonnett LJ, Tudur Smith C, Smith D, Williamson PR, Chadwick D, Marson AG. Time to 12-month remission and treatment failure for generalised and unclassified epilepsy. J Neurol Neurosurg Psychiatry. 2013;85(6):603–10.CrossRef
12.
go back to reference Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, et al A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess. 2007;11(37):iii-iv, ix-x, 1–134. Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, et al A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess. 2007;11(37):iii-iv, ix-x, 1–134.
13.
go back to reference Akaike H. A new look at the statistical model identification. Automatic Control IEEE Transactions On. 1974;19(6):716–23.CrossRef Akaike H. A new look at the statistical model identification. Automatic Control IEEE Transactions On. 1974;19(6):716–23.CrossRef
14.
go back to reference Royston P, Altman DG. Regression using fractional polynomials of continuous covariates - parsimonious parametric modeling. Appl Stat J Royal Stat Soc Series C. 1994;43(3):429–67. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates - parsimonious parametric modeling. Appl Stat J Royal Stat Soc Series C. 1994;43(3):429–67.
15.
go back to reference Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28(5):964–74.CrossRef Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28(5):964–74.CrossRef
16.
go back to reference Royston P, Sauerbrei W. Multivariable model-building - a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables: Wiley; 2008. Royston P, Sauerbrei W. Multivariable model-building - a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables: Wiley; 2008.
17.
go back to reference Royston P, Sauerbrei W. Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials. Methods Inf Med. 2005;44(4):561–71.CrossRef Royston P, Sauerbrei W. Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials. Methods Inf Med. 2005;44(4):561–71.CrossRef
18.
go back to reference Stone CJ. Additive regression and other nonparametric models. Ann Stat. 1985;13(2):689–705.CrossRef Stone CJ. Additive regression and other nonparametric models. Ann Stat. 1985;13(2):689–705.CrossRef
19.
go back to reference Prentice RL, Farewell VT. Relative risk and odds ratio regression. Annu Rev Public Health. 1986;7:35–58.CrossRef Prentice RL, Farewell VT. Relative risk and odds ratio regression. Annu Rev Public Health. 1986;7:35–58.CrossRef
20.
go back to reference Kim LG, Johnson TL, Marson AG, Chadwick DW. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol. 2006;5(4):317–22.CrossRef Kim LG, Johnson TL, Marson AG, Chadwick DW. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol. 2006;5(4):317–22.CrossRef
21.
go back to reference MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JWAS, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol. 2000;48(6):833–41.CrossRef MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JWAS, Shorvon SD. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol. 2000;48(6):833–41.CrossRef
22.
go back to reference Bonnett L, Smith CT, Smith D, Williamson P, Chadwick D, Marson AG. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial. Lancet Neurol. 2012;11(4):331–40.CrossRef Bonnett L, Smith CT, Smith D, Williamson P, Chadwick D, Marson AG. Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial. Lancet Neurol. 2012;11(4):331–40.CrossRef
23.
go back to reference Rizopoulos D Joint models for longitudinal and time-to-event data: with applications in R: chapman and hall/CRC; 2012. Rizopoulos D Joint models for longitudinal and time-to-event data: with applications in R: chapman and hall/CRC; 2012.
24.
go back to reference Schmidt W-P, Cairncross S, Barreto ML, Clasen T, Genser B. Recent diarrhoeal illness and risk of lower respiratory infections in children under the age of 5 years. Int J Epidemiol. 2009;38(3):766–72.CrossRef Schmidt W-P, Cairncross S, Barreto ML, Clasen T, Genser B. Recent diarrhoeal illness and risk of lower respiratory infections in children under the age of 5 years. Int J Epidemiol. 2009;38(3):766–72.CrossRef
25.
go back to reference Saunders LL, Selassie AW, Hill EG, Nicholas JS, Horner MD, Corrigan JD, et al. A population-based study of repetitive traumatic brain injury among persons with traumatic brain injury. Brain Inj. 2009;23(11):866–72.CrossRef Saunders LL, Selassie AW, Hill EG, Nicholas JS, Horner MD, Corrigan JD, et al. A population-based study of repetitive traumatic brain injury among persons with traumatic brain injury. Brain Inj. 2009;23(11):866–72.CrossRef
26.
go back to reference Sagara I, Giorgi R, Doumbo OK, Piarroux R, Gaudart J. Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data. Malaria Journal. 2014;13:293-. Sagara I, Giorgi R, Doumbo OK, Piarroux R, Gaudart J. Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data. Malaria Journal. 2014;13:293-.
Metadata
Title
Modelling seizure rates rather than time to an event within clinical trials of antiepileptic drugs
Authors
Laura J. Bonnett
Jane L. Hutton
Anthony G. Marson
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2020
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-020-00965-5

Other articles of this Issue 1/2020

BMC Medical Research Methodology 1/2020 Go to the issue